Rubeosis Iridis Or Neovascularization of the Iris in Diabetes

Rubeosis Iridis Or Neovascularization of the Iris in Diabetes

1/6/2021 Rubeosis iridis or neovascularization of the iris in diabetes (http://medicine.uiowa.edu/eye/) Search Ophthalmology and Visual Sciences (http://medicine.uiowa.edu/eye) (../../../index.htm) Rubeosis iridis or neovascularization of the iris in diabetes Contributor: Johanna Beebe (../../../bio/authors/Beebe-Dijkstal-Johanna.htm), MD and Jaclyn Haugsdal (../../../bio/authors/Haugsdal-Jaclyn.htm), MD Photographer: Cindy Montague, CRA This is a 57-year-old man with a past medical history of diabetes mellitus type 2, who presented to the ophthalmology clinic for decreased vision. His most recent hemoglobin A1c was 12.8%. Upon applanation his intraocular pressures were 11 mmHg OD and 32 mmHg OS. Both eyes had fine vessels coursing along the iris surface in an irregular path directed radially towards the angle. His anterior segment exam demonstrated tus of vessels along the pupillary margin in the le eye and fine vessel extending from the angle at 3 o'clock. There was a 1 mm layered hyphema in the le eye. On gonioscopy, he had a 35 degree angle and 360 degrees of neovascularization of the angle in both eyes. Posterior segment exam showed severe proliferative diabetic retinopathy in both eyes. Neovascularization of the iris (NVI), also known as rubeosis iridis, is when small fine, blood vessels develop on the anterior surface of the iris in response to retinal ischemia. These changes most oen develop at the pupillary border, but it is important to perform gonioscopy in order to investigate for involvement of the angle. Patients with NVI are prone to spontaneous hyphemas as these blood vessels are fragile and lend to bleeding. Patients with proliferative diabetic retinopathy who develop NVI are oen treated with panretinal photocoagulation with or without an intravitreal injection of an anti-VEGF medication. webeye.ophth.uiowa.edu/eyeforum/atlas/pages/NVI/index.htm 1/3 1/6/2021 Rubeosis iridis or neovascularization of the iris in diabetes (NVI-LRG.jpg) (nvi7-LRG.jpg) (nvi2-LRG.jpg) (nvi-5-LRG.jpg) (nvi3-LRG.jpg) (nvi6-LRG.jpg) (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en_US) Ophthalmic Atlas Images by EyeRounds.org, The University of Iowa (http://www.EyeRounds.org) are licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en_US). last updated: 02/26/2015 Share this page: webeye.ophth.uiowa.edu/eyeforum/atlas/pages/NVI/index.htm 2/3 1/6/2021 Rubeosis iridis or neovascularization of the iris in diabetes University of Iowa Carver College of Medicine Department of Ophthalmology & Visual Sciences 200 Hawkins Dr. Iowa City, IA 52242 Web Privacy Policy (http://www.uiowa.edu/homepage/online-privacy-information) | Nondiscrimination Statement (http://opsmanual.uiowa.edu/community-policies/nondiscrimination-statement) (http://www.uiowa.edu) Directory (https://www.dna.its.uiowa.edu/Whitepages/) | A-Z Search (http://www.uiowa.edu/a-z) | About Iowa (http://www.uiowa.edu/homepage/about-university) | Contact Us (http://www.uiowa.edu/homepage/about-university) | Calendars (http://www.uiowa.edu/homepage/calendars) | Privacy Information (http://www.uiowa.edu/homepage/online-privacy-information) copyright ©2016 The University of Iowa. webeye.ophth.uiowa.edu/eyeforum/atlas/pages/NVI/index.htm 3/3.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    3 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us